[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346071-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346071-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tumor-count-and-risk-of-lymph-node-metastasis-in-multiple-rectal-neuroendocrine-tumors-an-individual-level-pooled-analysis","Tumor count and risk of lymph node metastasis in multiple rectal neuroendocrine tumors - an individual-level pooled analysis","","Multiple rectal neuroendocrine tumors (RM-NETs) are rare, frequently small, and usually well differentiated, yet their lymph node metastasis (LNM) risk may be underestimated when assessment relies on size alone. This pooled individual-level analysis examines whether tumor count is associated with LNM. Literature from major databases through September 30, 2025, was screened and clinicopathological data were extracted and analyzed using ROC evaluation and exploratory multivariable logistic regression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tumor-count-and-risk-of-lymph-node-metastasis-in-multiple-rectal-neuroendocrine-tumors-an-individual-level-pooled-analysis/346071/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tumor-count-and-risk-of-lymph-node-metastasis-in-multiple-rectal-neuroendocrine-tumors-an-individual-level-pooled-analysis/346071.png","ImageObject",300,407,{"name":42,"@type":43},"Theodora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main question of the study on multiple rectal neuroendocrine tumors?","Question",{"text":63,"@type":64},"Whether tumor count is associated with the risk of lymph node metastasis in patients with RM-NETs, beyond what tumor size alone would suggest.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were eligible cases identified and pooled?",{"text":68,"@type":64},"Case reports and case series describing two or more histologically confirmed rectal NETs were searched from major databases through September 30, 2025, and individual-level clinicopathological data were extracted and pooled.",{"name":70,"@type":61,"acceptedAnswer":71},"What tumor count threshold was suggested for lymph node metastasis risk?",{"text":72,"@type":64},"An exploratory threshold of approximately seven lesions was suggested by ROC analysis, with higher LNM incidence in patients with ≥7 tumors than those with fewer than 7.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346071,1790386641,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","Xu etal. World Journal of Surgical Oncology (2026) 24:351  \n[https://doi.org/10.1186/s12957-026-04441-0](https://doi.org/10.1186/s12957-026-04441-0)  \nWorld Journal of Surgical Oncology  \nRESEARCH Open Access  \nTumor count and risk of lymph node   \nmetastasis in multiple rectal neuroendocrine tumors: an individual-level pooled analysis  \nJianguo Xu1, Jian Shi1, Yu Mu1, Nan Zhou1, Yechao Du1, Weiwei Lai1, Zhaoyong Wang2, Lina Zhang1, Zhongyan Chen3, Qian Ma1 and Yong-Ping Yang1*  \nAbstract  \nBackground Multiple rectal neuroendocrine tumors (RM-NETs) are a rare and underrecognized subtype of rectal neuroendocrine neoplasms. Although these tumors are usually small and well differentiated, their risk of lymph node metastasis (LNM) may be underestimated when tumor size is considered alone. Current guidelines do not distinguish RM-NETs from solitary lesions. This study investigated the association between tumor count and LNM in patients with RM-NETs.  \nMethods A comprehensive literature search of PubMed, Embase, Web of Science, and Scopus was performed from database inception to September 30, 2025. Published case reports and case series describing two or more histologically confirmed rectal NETs were screened for eligibility, and one additional institutional case was included. Individual-level clinicopathological data were extracted and pooled. Receiver operating characteristic analysis was used to explore the discriminative ability of tumor count for LNM, and exploratory multivariable logistic regression was performed to identify factors associated with LNM.  \nResults A total of 46 patients were included, comprising 45 patients from 17 published studies and one institutional case. The median age was 57 years, and 80.4% of patients were male. Most tumors measured ≤ 10 mm (91 . 3%) . LNM was identified in 8 patients (17 .4%) . ROC analysis suggested an exploratory threshold of approximately seven lesions. Patients with ≥ 7 tumors had a significantly higher incidence of LNM than those with fewer than 7 tumors, with rates of 46 . 7% and 3. 2%, respectively. In exploratory multivariable analysis, tumor count ≥ 7 remained associated with LNM. Conclusions Tumor count may help identify patients with RM-NETs who are at increased risk of LNM. In this pooled analysis, the exploratory threshold of approximately seven lesions should be regarded as hypothesis-generating rather than as a definitive clinical cutoff. In patients with extensive multifocal disease, this finding may warrant closer nodal staging and multidisciplinary discussion, even when the maximum lesion size is small. Further validation in larger multicenter cohorts is warranted.  \nTrial registration Not applicable.  \nKeywords Rectal neuroendocrine tumors, Tumor burden, Lymph node metastasis, Risk factor, Pooled analysis  \n*Correspondence:  \nYong-Ping Yang  \n[yongpingyang8301@jlu.edu.cn](yongpingyang8301@jlu.edu.cn)  \n1Department of General Surgery, The Second Hospital of Jilin University, Changchun 130041, China  \n2Department of Pathology, The Second Hospital of Jilin University, Changchun 130041, China  \n3Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun 130041, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons","cbCaidgMITsP4jog","https://ap.wps.com/l/cbCaidgMITsP4jog","pdf",1959901,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions","[{\"question\":\"What is the main question of the study on multiple rectal neuroendocrine tumors?\",\"answer\":\"Whether tumor count is associated with the risk of lymph node metastasis in patients with RM-NETs, beyond what tumor size alone would suggest.\"},{\"question\":\"How were eligible cases identified and pooled?\",\"answer\":\"Case reports and case series describing two or more histologically confirmed rectal NETs were searched from major databases through September 30, 2025, and individual-level clinicopathological data were extracted and pooled.\"},{\"question\":\"What tumor count threshold was suggested for lymph node metastasis risk?\",\"answer\":\"An exploratory threshold of approximately seven lesions was suggested by ROC analysis, with higher LNM incidence in patients with ≥7 tumors than those with fewer than 7.\"}]","Tumor count and risk of lymph node metastasis in multiple rectal neuroendocrine tumors - an individual-level pooled analysis | PDF",1790059943,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e800d182dcc9943e6289a7e6b7a44c5e.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92dc7de1dc9954b7e604f1789373bb1c.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7cd3847842da2401e1977b1118c4cc0.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/633064e30ef40a094e4d0caa00d4f495.webp",980,1306]